September 2012 Briefing - RheumatologyLast Updated: October 01, 2012.
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for September 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Pain Intensity in Juvenile Arthritis Varies Widely
FRIDAY, Sept. 28 (HealthDay News) -- In youth with juvenile idiopathic arthritis (JIA), pain intensity varies within days, impacting patient quality of life, according to a study published online Sept. 12 in Arthritis Care & Research.
Topical NSAIDs Effective for Chronic Musculoskeletal Pain
THURSDAY, Sept. 27 (HealthDay News) -- Topical nonsteroidal anti-inflammatory drugs (NSAIDs) can provide effective pain relief for chronic musculoskeletal pain in adults, according to a review published online Sept. 12 in The Cochrane Library.
Myogenes Identified for Spondyloarthritis Synovitis
THURSDAY, Sept. 27 (HealthDay News) -- There are disease-specific and inflammation-independent stromal alterations in spondyloarthritis (SpA) synovitis, according to a study published online Sept. 12 in Arthritis & Rheumatism.
Medicare Knee Replacement Numbers Up Over Last 20 Years
TUESDAY, Sept. 25 (HealthDay News) -- From 1991 to 2010 there was a 161.5 percent annual volume increase in primary total knee arthroplasty (TKA) among Medicare enrollees as well as an increase in per capita utilization, according to research published in the Sept. 26 issue of the Journal of the American Medical Association.
Gout Is Primary Indication in About 0.2 Percent of ER Visits
TUESDAY, Sept. 18 (HealthDay News) -- Gout is the primary indication in about 0.2 percent of emergency department visits annually, according to a study published online Sept. 4 in Arthritis Care & Research.
Study Looks at Pain Processing Abnormalities in Knee OA
MONDAY, Sept. 17 (HealthDay News) -- For patients with knee osteoarthritis (K-OA), the lack of correlation between clinical pain and radiographic evidence of disease severity may be due to central sensitization, according to a study published online Sept. 7 in Arthritis & Rheumatism.
Not All Docs/Nurses Want to Be Asked About Hand Hygiene
FRIDAY, Sept. 7 (HealthDay News) -- Although most health care workers (HCWs) appreciate the role of patients in preventing health care-associated infection, a considerable proportion are uncomfortable with patients asking about their hand hygiene, according to a letter published online Sept. 3 in the Archives of Internal Medicine.
Elevated Rheumatoid Factor Ups Risk of Developing RA
FRIDAY, Sept. 7 (HealthDay News) -- Individuals in the general population with elevated levels of rheumatoid factor have a significantly increased risk of developing rheumatoid arthritis, according to a study published online Sept. 6 in BMJ.
Score Can Assess One-Year Risk of Serious Infection in RA
THURSDAY, Sept. 6 (HealthDay News) -- A risk score based on rheumatoid arthritis (RA) disease characteristics and comorbidities has been developed and validated for assessing the one-year risk of serious infection, according to research published in the September issue of Arthritis & Rheumatism.
No Increased Risk of Cancer With Biologics in Rheumatoid Arthritis
TUESDAY, Sept. 4 (HealthDay News) -- For patients with rheumatoid arthritis (RA), the use of biologic response modifiers (BRMs) for at least six months is not associated with an increased risk of malignancy compared with placebo or other disease-modifying antirheumatic drugs (DMARDs), according to a study published in the Sept. 5 issue of the Journal of the American Medical Association.
In RA, Hand Surgery Improves Function, Appearance
MONDAY, Sept. 3 (HealthDay News) -- Treating rheumatoid arthritis (RA) patients with severe hand deformities with a silicone metacarpophalangeal joint arthroplasty (SMPA) procedure produces significant, long-term improvement in hand function and appearance, according to research published in the September issue of Arthritis Care & Research.